Delivery Order SPE2DB22D3501-SPE2DB25FWC99
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price type and a Ceiling Value of $2,763.00. The contract is not set aside and is for the provision of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $2,782.32 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product, with a period of performance through May 13, 2025. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania, and is a critical supplier of medical and pharmaceutical products to federal...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,763.00, is for the delivery of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of June 13, 2025. This award is not designated as a set-aside and is open to full and open competition. Amerisourcebergen...
- This federal contract award is for the delivery of PEGASYS 180 MCG/ML VIAL medical products to the Defense Logistics Agency (DLA). The contract, valued at $4,522.80, was awarded to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of December 3, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a...
- This federal contract award, valued at $4,055.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The contract covers the delivery of PEGASYS 180 MCG/ML VIALML, a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PEGASYS 180 MCG/0.5 ML SYRINGE 0.5ML medical supplies, with a ceiling value of $5,504.46 and a period of performance through May 16, 2025. The contract is a Firm Fixed Price Delivery Order, and is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and is registered in the System for Award...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,261.21 by the Defense Logistics Agency (DLA) for the supply of Pegasys 180 mcg/ml vials. The award, issued on July 28, 2025, is a firm fixed price contract with an ultimate completion date of July 29, 2025. This non-set-aside delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- This delivery order, valued at $6,855.38, was awarded to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under a child contract structure, leveraging the...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $955,432.36, is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,485.74, is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA. The IDC covers a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWC99Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price type and a ceiling value of $2,763.01. The contract is not set-aside and will be performed in Conshohocken, Pennsylvania. The contract is for the supply of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product. Amerisourcebergen Drug Corp is an experienced federal contractor, holding a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 6/23/25 |